 In 2004, the company acquired four other Serbian concerns, increasing its market share from 15% to 45% in the process.As of 2011, the company has a market share in terms of production and import of 30.7%.Hemofarm was bought by the German STADA Arzneimittel pharmaceutical group for 480 million euros in 2006.